The daily faecal loss was found to be in the range of 1 4-18 mEq (mean 5-7 mEq, n = 8). Thus there may be a large variation in faecal losses, and values as high as 26 mEq/24 hours have been recorded (Hayes and Robinson, 1965). Nevertheless, such losses are still small in comparison with the loss to the dialysate which, together with dietary intake, is the major factor in the potassium balance of the regular dialysis patient.
Summary
The diagnostic value of measurements of plasma and urinary luteinizing hormone (LH) has been studied in 209 patients with endocrine disease. In 44 patients puberty was either delayed or had failed to occur. In those with chromosomal abnormalities the LH levels were often within the normal range, whereas those with a pituitary cause usually had low levels. In boys with delayed puberty plasma LH levels rose before physical changes occurred and had prognostic value. In patients with later gonadal failure, men with impotence or infertility, and women with secondary amenorrhoea LH assays proved of little value, although in one case a premature menopause was suspected and six patients with anorexia nervosa had low LH levels.
Introduction
Knowledge of the levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in plasma or urine is likely to be of value in the diagnosis of a number of patients with endocrine disease. These include patients with delayed sexual maturation, deciding whether it is hypothalamic-pituitary or gonadal in origin and also whether there is just delay or probable failure of gonadotrophin secretion. Gonadotrophin assays may also help in the evaluation of patients with secondary failure of sexual fimction, secondary amenorrhoea in women, and impotence or infertility in men. Thirdly, gonadotrophin measurements should complement assays of corticotrophin, thyrotrophin, and growth hormone in the assessment ofhypothalamicpituitary fimction.
Methods have now been described for measuring the plasma and urinary concentrations of FSH and of LH (Franchimont, 1970; Lipsett et al., 1970) . FSH measurements present considerable practical difficulties but an LH assay has recently been made available in this country on a commercial basis, and the present study was started in December 1969 in an attempt to determine how far it would help to solve the diagnostic problems.
Method
The radioimmunoassay used involved highly purified LH (Dr. Anne Hartree-IRC-2) for labelling and an antibody raised in guinea-pigs to commercially available human chorionic gonadotrophin (HCG), and for plasma assays the standard used was the M.R.C. Research Standard A for human pituitary interstitial cell-stimulating hormone. Plasma results are expressed as mIU/ml of 2nd International Reference Preparation of human menopausal gonadotrophin (2nd IRP HMG), the conversion from M.R.C. Research Standard A being done by bioassay of the latter against 2nd IRP HMG. Urine assays were performed on extracts prepared by alcohol precipitation and the standard used was the 2nd IRP HMG. The assay employed a second antibody, a rabbit anti-guinea-pig serum. The coefficient of variation on a series of repeated samples measured in different assays was 11 %. The lowest detectable levels were: in plasma 0'4 mIU/ml and in urine 1'5 mIU/ml.
The normal values in this assay are shown in Table I . Details of the method are in preparation for publication. Details of the patients studied are shown in Table II . In 175 of these simultaneous assays of plasma and urine LH weremade; in others the measurements were made on the plasma or urine. Multiple assays were made in 80 of the patients. changes were occurring normally and in three with precocious puberty. Thirteen of the boys with delayed puberty had low plasma LH levels; the two with higher levels soon began to show pubertal changes. In five of the boys with low levels serial LH measurements were made over a period of up to 18 months and the results are shown in Fig. 2 ; with the increase of LH pubertal changes became apparent. Only a proportion of patients will improve in this way, and in three older patients, aged 22, 28, and 32 years, with plasma LH levels of 0 3, 13, and < 1-3 mIU/ml, a diagnosis of hypogonadotrophic hypogonad- hypopituitarism the LH levels were usually at the lower limit of normal or below, although there were two patients with significant amounts of LH in the plasma. Men not requiring replacement therapy had normal LH levels, apart from three in whom plasma LH was subnormal. The three menstruating women had normal levels.
Amenorrhoeic women aged under 50 and 50 and over are shown separately and the results compared with those of normal women in the follicular or luteal phases and after the menopause. The younger women showed a larger proportion of subnormal results. The three young women with primary amenorrhoea due to hypothalamic or pituitary disorder had plasma LH levels of 1 9, <0-8, and 1'5 mIU/ml and urine LH outputs of 6-0, 2-0, 2-4 IU/24 hours. Of the 60 patients in this section, 51 had simul-taneous plasma and urine LH estimations. Good agreement was obtained in 36 patients, mostly in the panhypopituitary and normal groups. Discordant results were encountered among the amenorrhoeic women under 50, five of whom had normal urine but low plasma levels and three the opposite.
Serial plasma or urine LH measurements were made on 11 patients having surgical treatment (five acromegalics, five with chromophobe adenoma, and one with chordoma). In three the LH levels were higher after operation, in six there was a fall, and in two no obvious change. The three patients in whom the LH levels rose had transsphenoidal hypophysectomies for acromegaly (Mr. R. A. Williams).
Discussion
In the investigation of patients with primary gonadal failure published data available suggest that FSH measurements are of more value than LH estimations in the younger age groups (Franchimont, 1970; Penny et al., 1970) . In older patients serum LH levels above the normal range have been found (Anderson et al., 1971) . The figures given in Table V (Franchimont, 1971) .
In patients with hypothalamic-pituitary disturbance the estimation of plasma LH is of undoubted value. Low levels were obtained in most of the patients with hypopituitarism, in women with amenorrhoea but normal TSH and ACTH production, and in a proportion of postmenopausal women. It was of particular value in screening the latter group. Evidence to date suggests that LH is one of the first hormones to be lost in pituitary dysfunction due to hypothalamic-pituitary disorders. Single urine LH assays were sometimes misleading. LH determinations before and after clomiphene administration may be a better indication of hypothalamic-pituitary fimction (Newton et al., 1971) .
Assays of gonadotrophins are in a developmental stage. The choice of suitable standards for plasma and urine assays is still a matter for discussion and probably the results obtained in the various clinical situations will also depend on the particular antibody being used. Any figures for normal range and assessment of diagnostic value must specify standards, materials used for iodination, and antibody. In men and in women apart from the ovulatory peak the plasma LH seems to be reasonably constant, although it is probably advisable to have two or three estimations in any particular patient. M. J. Gallagher and M. Tidd (unpublished) found that in normal men serial urine assays give results over a wide range. It would therefore seem necessary to have serial assays before attaching diagnostic significance to the results of urine LH output estimations.
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